Literature DB >> 12573173

Tobacco harm reduction: conceptual structure and nomenclature for analysis and research.

Saul Shiffman1, Joe G Gitchell, Kenneth E Warner, John Slade, Jack E Henningfield, John M Pinney.   

Abstract

The goal of tobacco control has always been to reduce death and disease due to tobacco use. Recent discussions have broadened the concept of tobacco control beyond cessation and prevention to include concepts such as the use of medications to achieve reduction in tobacco use, chemoprevention to reduce disease, modifications of tobacco products to reduce toxicity, and behavioral approaches to change smoking and tobacco use behavior. Within each of these broad domains, diverse approaches have been suggested. To facilitate clear discussion and analysis, and to avoid confusion among approaches, we catalog 19 approaches to harm reduction, distinguishing and discussing them on 11 dimensions, including their objectives, mechanisms, toxicology, expected population risks, and consumer appeal. Because there have also been so many suggested applications of medicinal nicotine to smoking intervention, we separately catalog and analyze nine applications, some of which constitute new approaches to harm reduction. The suggested framework is intended to clarify the debate, provide for common nomenclature, and facilitate analysis of diverse approaches to tobacco harm reduction.

Entities:  

Mesh:

Year:  2002        PMID: 12573173     DOI: 10.1080/1462220021000032717

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  26 in total

Review 1.  Regulatory strategies to reduce tobacco addiction in youth.

Authors:  J E Henningfield; E T Moolchan; M Zeller
Journal:  Tob Control       Date:  2003-06       Impact factor: 7.552

2.  Smoker and ex-smoker reactions to cigarettes claiming reduced risk.

Authors:  S Shiffman; J L Pillitteri; S L Burton; M E Di Marino
Journal:  Tob Control       Date:  2004-03       Impact factor: 7.552

Review 3.  Do smoking reduction interventions promote cessation in smokers not ready to quit?

Authors:  Taghrid Asfar; Jon O Ebbert; Robert C Klesges; George E Relyea
Journal:  Addict Behav       Date:  2011-02-12       Impact factor: 3.913

Review 4.  The feasibility of smoking reduction: an update.

Authors:  John R Hughes; Matthew J Carpenter
Journal:  Addiction       Date:  2005-08       Impact factor: 6.526

5.  The fourth pillar of the Framework Convention on Tobacco Control: harm reduction and the international human right to health.

Authors:  Benjamin Mason Meier; Donna Shelley
Journal:  Public Health Rep       Date:  2006 Sep-Oct       Impact factor: 2.792

6.  A lack of association between severity of nicotine withdrawal and individual differences in compensatory nicotine self-administration in rats.

Authors:  Andrew C Harris; Paul R Pentel; Danielle Burroughs; Mylissa D Staley; Mark G Lesage
Journal:  Psychopharmacology (Berl)       Date:  2011-04-15       Impact factor: 4.530

7.  Association of post-treatment smoking change with future smoking and cessation efforts among adolescents with psychiatric comorbidity.

Authors:  Laura MacPherson; David R Strong; Christopher W Kahler; Ana M Abrantes; Susan E Ramsey; Richard A Brown
Journal:  Nicotine Tob Res       Date:  2007-12       Impact factor: 4.244

Review 8.  Postmarketing surveillance for "modified-risk" tobacco products.

Authors:  Richard J O'Connor
Journal:  Nicotine Tob Res       Date:  2011-01-20       Impact factor: 4.244

9.  Truth and Memory: Linking Instantaneous and Retrospective Self-Reported Cigarette Consumption.

Authors:  Hao Wang; Saul Shiffman; Sandra D Griffith; Daniel F Heitjan
Journal:  Ann Appl Stat       Date:  2012       Impact factor: 2.083

Review 10.  Surveillance methods for identifying, characterizing, and monitoring tobacco products: potential reduced exposure products as an example.

Authors:  Richard J O'Connor; K Michael Cummings; Vaughan W Rees; Gregory N Connolly; Kaila J Norton; David Sweanor; Mark Parascandola; Dorothy K Hatsukami; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.